Effects of interleukin (IL)-3 and IL-5 on human eosinophil degranulation induced by complement components C3a and C5a

Allergy: European Journal of Allergy and Clinical Immunology

Volumn 51, Issue 8, 1996, Pages 563-568

  Takafuji, S ^a,b   Tadokoro, K ^a,b   Ito, K ^a,b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Tokyo Red Cross Blood Center   (Japan)

Author keywords

Complement; Cytokine; Degranulation; Eosinophil

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; INTERLEUKIN 3; INTERLEUKIN 5; PROTEIN;

ADULT; ARTICLE; ASTHMA; EOSINOPHIL; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

EID: 0029819679     PISSN: 01054538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1398-9995.1996.tb04669.x     Document Type: Article

References (25)

1. Sedgwick JB, Calhoun \VJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmentai antigen challenge: characterization of eosinophil and mast cell mediators. Am Rev Respir Dis 1991;144:1274-81.
2. Frigas E, Gleich GJ. The eosinophil and the pathophysiology of asthma. J Allergy Clin Immunol 1986;77:527-37.
3. Frigas E, Loegering DA, Solley GO, Farrow GW, Gleich GJ. Elevated levels of the eosinophil granule major basic protein in the sputum of patient with bronchial asthma. Mayo Clin Proc 1981;56:345-53.
4. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990;85:422-36.
5. Kroegel C, Yukawa T, Dent G, Venge P, Chung KF, Barnes PJ. Stimulation of degranulation from human eosinophils by platelet-activating factor. J Immunol 1989;142:3518-26.
6. Abu-Ghazaleh RI, Fujisawa T, Mestecky J, Kyle RA, Gleich GJ. IgA-induced eosinophil degranulation. J Immunol 1989;142:2393-2400.
7. Fujisawa T, Abu-Ghazaleh R, Kita H, Sanderson CJ, Gleich GJ. Regulatory effect of cytokines on eosinophil degranulation. J Immunol 1990;144:642-6.
8. Carlson M, Hâkansson L, Peterson C, Stâlenheim G, Venge P. Secretion of granule proteins from eosinophils and neutrophils is increased in asthma. J Allergy Clin Immunol 1991;87:27-33.
9. Arroyave CM, Stevenson DD, Vaughan JH, Tan FM. Plasma component changes during bronchospasm provoked in asthmatic patients. Clin Allergy 1977;7:173-82.
10. Callerame ML, Condemi JJ, Milton G, Bohrod MG, Vaughan JH. Immunologie reactions of bronchial tissues in asthma. N Engl J Med 1971;284:459-64.
11. van der Zee JS, van Swieten P, Aalberse RC. Activation of the classical pathway of human complement in vitro by house-dust extracts is caused by IgM antibodies to polysaccharide antigen(s) and is not related to atopy. Mol Immunol 1988;25:345-54.
12. Edwards JH. A quantitative study on the activation of the alternative pathway of complement by mouldy-hay dust and thermophilic actinomycetes. Clin Allergy 1976; 6:19-25.
13. Olenchock SA, Mull JC, Major PC. Extracts of airbornegrain dusts activate alternative and classical complement pathways. Ann Allergy 1980;44:23-8.
14. Takafuji S, Bischoff SC, de Weck AL, Dahinden CA. IL-3 and IL-5 prime normal human eosinophils to produce leukotriene C4 in response to soluble agonists. J Immunol 1991;147:3855-61.
15. Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991; 145:105-10.
16. Hugli TE, Gerard C, Kawahara M, et al. Isolation of three separate anaphylatoxins from complement-activated human serum. Mol Cell Biochem 1981;41:59-66.
17. Takafuji. S, Bischoff SC, de Weck AL, Dahinden CA. Opposing effects of tumor necrosis factor-a and nerve growth factor upon leukotriene C4 production by human eosinophils triggered with N-formyl-methionyl-leucyl-phenylalanine. Eur J Immunol 1992;22:969-74.
18. Kernen P, Wymann MP, von Tscharner V, et al. Shape changes, exocytosis, and cytosolic free calcium changes in stimulated human eosinophils. J Clin Invest 1991;87:2012-17.
19. Zeck-Kapp G, Kroegel C, Riede UN, Kapp A. Mechanisms of human eosinophil activation by complement protein C5a and platelet-activating factor: similar functional responses are accompanied by different morphologic alterations. Allergy 1995;50:34-47.
20. Aunis D, Bader MR. The cytoskeleton as a barrier to exocytosis in secretory cells. J Exp Biol 1988;139:253-66.
21. Bengtsson T, Dahlgren C, Stendahl O, Andersson T. Actin assembly and regulation of neutrophil function: effects of cytochalasin B and tetracaine on chemotactic peptideinduced O~2 production and degranulation. J Leukoc Biol 1991;49:236-44.
22. Dahinden C, Fehr J. Granulocyte activation by endotoxin. II. Role of granulocyte adherence, aggregation, and effect of cytochalasin B, and comparison with formylated chemotactic peptide-induced stimulation. J Immunol 1983; 130:863-8.
23. Horie S, Kita H. CDllb/CD18(Mac-l) is required for degranulation of human eosinophils induced by human recombinant granulocyte-macrophage colony-stimulating factor and platelet-activating factor. J Immunol 1994; 152:5457-67.
24. Egesten A, Gullberg U, Olsson I, Richter J. Phorbol esterinduced degranulation in adherent human eosinophil granulocytes is dependent on CD11/CD18 leukocyte integrins. J Leukoc Biol 1993;53:287-93.
25. Takafuji S, Ohtoshi T, Takizawa H, Tadokoro K, Ito K. Eosinophil degranulation in the presence of bronchial epithelial cells - effect of cytokines and role of adhesion. J Immunol 1996;156:3980-5.